On July 21, 2022, the Board of Directors for BoxScore Brands, Inc. (the Company) (the “Board”) received the Resignation of Mr. Andrew Boutsikakis from his positions as Director for the Company. There are no disputes or disagreements between Mr. Boutsikakis and the Company. On the same date, the Board unanimously voted to increase the number of Directors on the Board to five (5), and subsequently approved and appointed Dr. Adam Lipson as a Director and Mr. David Graber as a Director for the Company.

Dr. Adam Lipson is currently managing partner as a neurosurgeon at IGEA Brain, Spine & Orthopedics in New York City and New Jersey. He has over a decade of experience as a private investor in over 20 biotechnology and biomedical device companies. He has co-founded several other companies, including IGEA Ventures and STRYDD.

He is passionate about finding technologies that facilitate advances in energy transition, biomedical devices, and cancer therapeutics. Dr. Lipson is a graduate of Dartmouth College 1995 with a B.A. in Chemistry and History and Harvard Medical School M.D. Cum Laude and Honors Society in Neuroscience 2000, and was a Fullbright Fellow at Karolinska Institute in Stockholm, Sweden in 1999. David Graber is the Managing Principal of Cobrador Capital Advisors, LLC.

From February 2017 to November 2018, Mr. Graber was CEO and CFO of BoxScore Brands, Inc. Prior to Cobrador Capital Advisors, LLC, Mr. Graber was Managing Director, Investment Banking at New Century Capital Partners (2011-2014) and National Securities Corporation (2009-2010). From 1994-2005 Mr. Graber was a Sr. Vice President and Director in the Equities Division of Donaldson, Lufkin & Jenrette and subsequently, Credit Suisse First Boston (CSFB) in New York and Los Angeles. Mr. Graber holds dual Master of Business Administration (MBA) from Columbia University Graduate School of Business (2004) in New York City and London Business School in the UK (2004).

He also holds a BA Psychology from Tulane University in New Orleans, LA.